Insmed INSM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$163.56M+50.2% | -$328.49M+11.2% | -$370.02M-15.0% | -$321.69M-25.4% | -$256.58M-8.9% | ||
| $2.93M-19.0% | $3.62M+47.4% | $2.46M-1.0% | $2.48M+31.9% | $1.88M+27.4% | ||
| $45.75M+17.2% | $39.04M+24.2% | $31.43M-26.9% | $42.98M+9.5% | $39.26M+47.9% | ||
| $1.38M+0.4% | $1.38M+2.5% | $1.34M-19.9% | $1.68M-8.0% | $1.82M+4.2% | ||
| $38.19M-50.6% | $77.3M+656% | $10.23M+66.5% | $6.14M+215% | -$5.36M-145% | ||
| $1.89M-84.0% | $11.76M-14.5% | $13.76M+176% | $4.98M+387% | $1.02M-51.9% | ||
| -$33.88M-137% | $90.35M+98.3% | $45.56M+77.6% | $25.66M+142% | -$61.49M-250% | ||
| $2.36M-80.0% | $11.79M+313% | $2.85M+221% | -$2.35M+76.9% | -$10.17M-275% | ||
| -$497K+45.6% | -$914K+16.6% | -$1.1M-34.5% | -$815K+62.4% | -$2.17M+52.7% | ||
| $5.11M-4.1% | $5.33M+3.9% | $5.13M-1.2% | $5.19M+3.4% | $5.02M-0.8% | ||
| $2.08M+7.4% | $1.94M+25.9% | $1.54M+21.8% | $1.26M0.0% | $1.26M0.0% | ||
| -$46.96M-167% | $70.04M-33.1% | $104.65M+77.4% | $59M+222% | $18.3M— | ||
| -$222.74M+10.0% | -$247.6M-12.7% | -$219.76M-6.9% | -$205.57M+21.6% | -$262.09M-33.7% | ||
| $3.48M-79.0% | $16.59M+586% | $2.42M-30.6% | $3.48M-65.4% | $10.07M+48.7% | ||
| $284M-34.9% | $436M+2.6% | $425M-16.3% | $508M-29.5% | $721M+0.7% | ||
| $265.52M— | —— | -$762.23M-435% | $227.84M+183% | $80.41M— | ||
| $30.31M— | —— | —— | $793.83M+2,572% | $29.7M— | ||
| $799K+3.0% | $776K+3.9% | $747K+2.0% | $732K+3.7% | $706K+2.9% | ||
| $29.51M-12.8% | $33.86M+1.3% | $33.41M-96.1% | $857.81M+2,858% | $29M-81.8% | ||
| -$553K-8,000% | $7K— | —— | $1.01M+12.3% | $895K+159% | ||
| $71.74M— | —— | -$949.56M-208% | $881.08M+680% | -$151.78M-262% | ||
| $13.12M-2.9% | $13.51M-12.6% | $15.45M+16.5% | $13.27M+1.1% | $13.12M-13.9% | ||
| $2.94M+2,549% | $111K-90.6% | $1.18M+73.9% | $677K-68.9% | $2.18M+777% | ||
| $1.38M+0.4% | $1.38M+2.5% | $1.34M-19.9% | $1.68M-8.0% | $1.82M+4.2% | ||
| $2.08M+7.4% | $1.94M+25.9% | $1.54M+21.8% | $1.26M0.0% | $1.26M0.0% | ||
| -$46.96M-167% | $70.04M-33.1% | $104.65M+77.4% | $59M+222% | $18.3M— | ||
| $2.93M-19.0% | $3.62M+47.4% | $2.46M-1.0% | $2.48M+31.9% | $1.88M+27.4% | ||
| -$12.59M-148% | $26.22M+603% | $3.73M-42.9% | $6.53M-61.4% | $16.94M— | ||
| $567K-91.8% | $6.9M+488% | $1.17M+32.2% | $888K+29.4% | $686K-49.5% | ||
| $15M— | —— | —— | —— | $0— | ||
| $799K+3.0% | $776K+3.9% | $747K+2.0% | $732K+3.7% | $706K+2.9% | ||
| $678K0.0% | $678K0.0% | $678K0.0% | $678K0.0% | $678K0.0% | ||
| $2.94M+2,549% | $111K-90.6% | $1.18M+73.9% | $677K-68.9% | $2.18M+777% | ||
| -$226.22M+14.4% | -$264.19M-18.9% | -$222.18M-6.3% | -$209.05M+23.2% | -$272.16M-34.2% | ||
| -$226.22M+14.4% | -$264.19M-18.9% | -$222.18M-6.3% | -$209.05M+23.2% | -$272.16M-34.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insmed generate?
- Insmed (INSM) generated -$895.7M in operating cash flow over the trailing twelve months.
- What is Insmed's free cash flow?
- After $26.0M of capital expenditures, Insmed's free cash flow was -$921.6M over the trailing twelve months, down 16.8% year over year.
- Where does Insmed's cash flow data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
